Thapa, Ram

HDAC8 regulates a stress response pathway in melanoma to mediate escape from BRAF inhibitor therapy

Emmons, M. F., Faião-Flores, F., Sharma, R., Thapa, R., Messina, J. L., Becker, J. C., Schadendorf, D., Seto, E., Sondak, V. K., Koomen, J. M., et al. (2019) · Cancer Research

Melanoma and MAPK PathwaysHistone Deacetylase Inhibitors Research

Cited by 73

Randomized-controlled phase II trial of salvage chemotherapy after immunization with a TP53-transfected dendritic cell-based vaccine (Ad.p53-DC) in patients with recurrent small cell lung cancer

Chiappori, A. A., Williams, C. C., Gray, J. E., Tanvetyanon, T., Haura, E. B., Creelan, B. C., Thapa, R., Chen, D.-T., Simon, G. R., Bepler, G., et al. (2019) · Cancer Immunology, Immunotherapy

Immunotherapy and Immune ResponsesLung Cancer Research Studies

Cited by 64

Phase II randomized trial of first-line pembrolizumab and vorinostat in patients with metastatic NSCLC (mNSCLC): Final results.

Saltos, A. N., Tanvetyanon, T., Creelan, B. C., Shafique, M. R., Antonia, S. J., Haura, E. B., Zheng, H., Yu, X., Saller, J. J., Viracacha, S., et al. (2023) · Journal of Clinical Oncology

Cancer Immunotherapy and BiomarkersLung Cancer Treatments and Mutations

Cited by 9

The prevalence of luminal B subtype is higher in older postmenopausal women with ER+/HER2- breast cancer and is associated with inferior outcomes

Mills, M., Liveringhouse, C., Lee, F., Nanda, R. H., Ahmed, K. A., Washington, I. R., Thapa, R., Fridley, B. L., Blumencranz, P., Extermann, M., et al. (2021) · Journal of Geriatric Oncology

Breast Cancer Treatment StudiesMenopause: Health Impacts and Treatments

Cited by 7